Population classification	Approximate age	Preferred vaccine type
Routine vaccination
Adolescents at routine checkup	11 to 12 years	MCV4 (Menactra)
Adolescents (who have not previously received MCV4) before high school entry	15 years	MCV4
Patients at increased risk for meningococcal disease
College freshmen living in dormitories	17 to 24 years	MCV4 (MPSV4 [Menomune] acceptable)
Military recruits	18 years or older	MCV4 (MPSV4 acceptable)
Microbiologists routinely exposed to Neisseria meningitidis	Adult	MCV4 (MPSV4 acceptable)
Persons with anatomic or functional asplenia or terminal complement deficiencies	Two to 10 years of age or older than 55 years	MPSV4
	11 to 55 years of age	MCV4
Travelers to countries where N. meningitidis is hyperendemic or epidemic, especially sub-Saharan Africa or Saudi Arabia	Two to 10 years of age or older than 55 years	MPSV4
	11 to 55 years of age	MCV4
Patients with HIV*	11 years35 or older (elective)	MCV4 or MPSV4